HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sharon Baptiste-Brown Selected Research

GSK2485852

11/2014A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sharon Baptiste-Brown Research Topics

Disease

1Chronic Hepatitis B
10/2022
1Infections
10/2022
1Liver Diseases (Liver Disease)
10/2022
1Liver Neoplasms (Liver Cancer)
10/2022
1Hepatitis C
11/2014
1Glucosephosphate Dehydrogenase Deficiency
12/2013
1Vivax Malaria
12/2013

Drug/Important Bio-Agent (IBA)

1Proteins (Proteins, Gene)FDA Link
10/2022
1Viral ProteinsIBA
10/2022
1GSK2485852IBA
11/2014
1Antiviral Agents (Antivirals)IBA
11/2014
1Chloroquine (Aralen)FDA LinkGeneric
12/2013
18-aminoquinolineIBA
12/2013
1tafenoquineIBA
12/2013

Therapy/Procedure

2Therapeutics
10/2022 - 12/2013